Emerging Diagnostic Modalities & Innovation
|1 min read
Potential Biomarker for Autism
|4 min read
Researchers Predict Risk for Common Deadly Diseases from Millions of Genetic Variants
Through this "polygenic risk scoring," researchers can identify people at high risk for disease, even if they don't present other warning signs
|2 min read
New RNA, DNA-Sequencing Platform Matches Thousands of Drugs to Late-Stage Cancer Patients
A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them
|4 min read
A Targeted Approach to Treating Glioma
With a new method, surgeons would remove a tumor, then implant microparticles that attack the remaining cancer cells
|2 min read
Researchers Identify Potential Diagnostic Test for Kawasaki Disease
For the first time, researchers have determined that Kawasaki Disease can be accurately diagnosed on the basis of the pattern of host gene expression in whole blood
|2 min read
Epigenetic Markers of Ovarian Cancer
John Hopkins researchers, in collaboration with Insilico Medicine, identify that silencing of the GULP1 gene expression by methylation plays an important role in ovarian carcinogenesis
|2 min read
Big-Data Study Pinpoints More Than 150 Genes Associated with Atrial Fibrillation
The study also develops a genetic risk score for atrial fibrillation
|2 min read
Latent TB Treatment: Shorter Is Better
Game-changing study on treatment of latent Tuberculosis shows a novel, short therapy is safer and more effective in children and adults than standard therapy
|2 min read
New Cell Lines Produce NIST Monoclonal Antibody for Improved Biologic Drugs
Monoclonal antibodies are proteins manufactured in the laboratory that can target specific disease cells, viruses, and other antigens
|3 min read
